Clinical Trial Update: Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB [Phase 2]

View source ↗

Summary

A Phase 2 global multicenter platform trial by University College London evaluating different regimens and treatment durations for pulmonary tuberculosis, curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis Pulmonary

Snippet

Sponsor: University College, London | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: RECRUITING